IBM Goes for Unity

Courtesy of IBMA new effort to unify the naming conventions of biological data is now underway in labs and companies throughout the world. The Life Science Identifier (LSID) Resolution Protocol Project consists of two software programs and a set of naming standards http://www.ibm.com/developerworks/oss/lsid.The first program is a server application called LSID Authority, which allows database and Web-site managers to identify their data with LSID URNs (uniform resource names, similar to URLs). T

Written bySam Jaffe
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of IBM

A new effort to unify the naming conventions of biological data is now underway in labs and companies throughout the world. The Life Science Identifier (LSID) Resolution Protocol Project consists of two software programs and a set of naming standards http://www.ibm.com/developerworks/oss/lsid.

The first program is a server application called LSID Authority, which allows database and Web-site managers to identify their data with LSID URNs (uniform resource names, similar to URLs). The second program is a client search package called LSID Resolver, which allows anyone to search for particular information through a distributed network. "Eventually, you can use it to run on any computer to find every piece of available information on a particular life sciences-related item," says Sean Martin, a senior technical senior staff member at IBM's Advanced Internet Technology Group, who helped to program the software.

How does the system work? Say you're looking for information ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies